| Exacerbation Study (NCT00845728) | Novartis Pharmaceuticals | 2009-03-01 |
| Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients (NCT00853827) | Novartis Pharmaceuticals | 2009-03-01 |
| Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis (NCT00809614) | Novartis Pharmaceuticals | 2009-03-01 |
| Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors (NCT01285453) | Novartis Pharmaceuticals | 2009-03-01 |
| Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B (NCT00877149) | Novartis Pharmaceuticals | 2009-03-01 |
| Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure (NCT00853658) | Novartis Pharmaceuticals | 2009-03-01 |
| Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors (NCT00880308) | Novartis Pharmaceuticals | 2009-03-01 |
| Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma (NCT00870584) | Novartis Pharmaceuticals | 2009-03-01 |
| A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients (NCT00862979) | Novartis Pharmaceuticals | 2009-02-24 |
| Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B (NCT00907894) | Novartis Pharmaceuticals | 2009-02-01 |
| The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration (NCT00857259) | Novartis Pharmaceuticals | 2009-02-01 |
| Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec (NCT00879242) | Novartis Pharmaceuticals | 2009-02-01 |
| Tasigna in Glivec-resistant or Intolerant Patients in CML (NCT01206088) | Novartis Pharmaceuticals | 2009-02-01 |
| Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function (NCT01569815) | Novartis Pharmaceuticals | 2009-02-01 |
| Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 Diabetes (NCT00860288) | Novartis Pharmaceuticals | 2009-02-01 |
| Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease (NCT00770601) | Novartis Pharmaceuticals | 2009-01-26 |
| Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD) (NCT00821093) | Novartis Pharmaceuticals | 2009-01-01 |
| A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase (NCT01126892) | Novartis Pharmaceuticals | 2009-01-01 |
| Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension (NCT00846989) | Novartis Pharmaceuticals | 2009-01-01 |
| A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients (NCT00741377) | Novartis Pharmaceuticals | 2009-01-01 |
| Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients (NCT00826371) | Novartis Pharmaceuticals | 2009-01-01 |
| Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia (NCT00825539) | Novartis Pharmaceuticals | 2009-01-01 |
| Effect of AIN457 on Ozone-induced Airway Neutrophilia Compared to Placebo and Corticosteroid in Healthy Subjects (NCT00920933) | Novartis Pharmaceuticals | 2009-01-01 |
| Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia (NCT00748189) | Novartis Pharmaceuticals | 2008-12-22 |
| An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids (NCT00799266) | Novartis Pharmaceuticals | 2008-12-04 |
| Multiple-loading Dose Regimen Study in Patients With Chronic Plaque-type Psoriasis (NCT00805480) | Novartis Pharmaceuticals | 2008-12-01 |
| Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients (NCT00818571) | Novartis Pharmaceuticals | 2008-12-01 |
| Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload (NCT01335035) | Novartis Pharmaceuticals | 2008-12-01 |
| A Single Center Study to Characterize the Absorption, Distribution, Metabolism and Excretion (ADME) of ASA404 After a Single Infusion in Patients With Solid Tumors (NCT01299701) | Novartis Pharmaceuticals | 2008-12-01 |
| A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer (NCT00738387) | Novartis Pharmaceuticals | 2008-12-01 |
| A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study) (NCT00819585) | Novartis Pharmaceuticals | 2008-12-01 |
| A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer (NCT00788931) | Novartis Pharmaceuticals | 2008-12-01 |
| Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial (NCT01368523) | Novartis Pharmaceuticals | 2008-12-01 |
| Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma (NCT00828594) | Novartis Pharmaceuticals | 2008-12-01 |
| Phase I Study to Determine the Maximum Tolerate Dose (MTD) of BGT226 in Advanced Solid Tumors in Japan (NCT00742105) | Novartis Pharmaceuticals | 2008-11-17 |
| Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer (NCT00719264) | Novartis Pharmaceuticals | 2008-11-12 |
| Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan (NCT01132625) | Novartis Pharmaceuticals | 2008-11-01 |
| An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) (NCT00787917) | Novartis Pharmaceuticals | 2008-11-01 |
| Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. (NCT01289028) | Novartis Pharmaceuticals | 2008-11-01 |
| Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients (NCT01068483) | Novartis Pharmaceuticals | 2008-11-01 |
| Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD) (NCT00792805) | Novartis Pharmaceuticals | 2008-11-01 |
| Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study (NCT00873041) | Novartis Pharmaceuticals | 2008-11-01 |
| Safety and Efficacy of LCL161 in Patients With Solid Tumors (NCT01098838) | Novartis Pharmaceuticals | 2008-11-01 |
| Intra-venous Zoledronic Acid Once Yearly (NCT00984893) | Novartis Pharmaceuticals | 2008-11-01 |
| Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00794157) | Novartis Pharmaceuticals | 2008-11-01 |
| Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB (NCT00805675) | Novartis Pharmaceuticals | 2008-11-01 |
| Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB) (NCT00774020) | Novartis Pharmaceuticals | 2008-10-30 |
| Re-treatment of Participants With Paget's Disease Using Zoledronic Acid (NCT00740129) | Novartis Pharmaceuticals | 2008-10-21 |
| Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia (NCT00782067) | Novartis Pharmaceuticals | 2008-10-13 |
| Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer (NCT00667251) | Novartis Pharmaceuticals | 2008-10-07 |
| Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. (NCT00776009) | Novartis Pharmaceuticals | 2008-10-01 |
| Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy (NCT00784212) | Novartis Pharmaceuticals | 2008-10-01 |
| Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents (NCT00790816) | Novartis Pharmaceuticals | 2008-10-01 |
| Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib (NCT00644878) | Novartis Pharmaceuticals | 2008-10-01 |
| Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma (NCT00742027) | Novartis Pharmaceuticals | 2008-09-16 |
| A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension (NCT00758524) | Novartis Pharmaceuticals | 2008-09-11 |
| Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis (NCT00770965) | Novartis Pharmaceuticals | 2008-09-10 |
| Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma (NCT00414765) | Novartis Pharmaceuticals | 2008-09-03 |
| Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib (NCT00718562) | Novartis Pharmaceuticals | 2008-09-01 |
| Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) (NCT01110668) | Novartis Pharmaceuticals | 2008-09-01 |
| Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension (NCT00739973) | Novartis Pharmaceuticals | 2008-09-01 |
| A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer (NCT00670553) | Novartis Pharmaceuticals | 2008-09-01 |
| Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients (NCT00820911) | Novartis Pharmaceuticals | 2008-09-01 |
| Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema (NCT00768040) | Novartis Pharmaceuticals | 2008-09-01 |
| Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase (NCT00905593) | Novartis Pharmaceuticals | 2008-09-01 |
| Phase I Dose Escalating Study of TKI258 (NCT01471548) | Novartis Pharmaceuticals | 2008-09-01 |
| A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases (NCT00757757) | Novartis Pharmaceuticals | 2008-09-01 |
| Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib (NCT00756509) | Novartis Pharmaceuticals | 2008-08-29 |
| Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy (NCT00702052) | Novartis Pharmaceuticals | 2008-08-22 |
| Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma (NCT00720941) | Novartis Pharmaceuticals | 2008-08-14 |
| Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease (NCT00584740) | Novartis Pharmaceuticals | 2008-08-01 |
| Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off (NCT00601978) | Novartis Pharmaceuticals | 2008-08-01 |
| Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase (NCT00786812) | Novartis Pharmaceuticals | 2008-08-01 |
| Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis (NCT00704678) | Novartis Pharmaceuticals | 2008-08-01 |
| Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET) (NCT01528241) | Novartis Pharmaceuticals | 2008-08-01 |
| Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) (NCT01172548) | Novartis Pharmaceuticals | 2008-08-01 |
| Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B (NCT00781105) | Novartis Pharmaceuticals | 2008-08-01 |
| Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients (NCT01269684) | Novartis Pharmaceuticals | 2008-08-01 |
| Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid (NCT00745485) | Novartis Pharmaceuticals | 2008-08-01 |
| This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. (NCT00731692) | Novartis Pharmaceuticals | 2008-07-28 |
| Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC (NCT00709761) | Novartis Pharmaceuticals | 2008-07-02 |
| A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma. (NCT00708292) | Novartis Pharmaceuticals | 2008-07-01 |
| A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer (NCT00715182) | Novartis Pharmaceuticals | 2008-07-01 |
| Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis (NCT00704483) | Novartis Pharmaceuticals | 2008-07-01 |
| Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function (NCT00698464) | Novartis Pharmaceuticals | 2008-07-01 |
| Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease. (NCT00731224) | Novartis Pharmaceuticals | 2008-07-01 |
| Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African Americans (NCT00739596) | Novartis Pharmaceuticals | 2008-07-01 |
| Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors (NCT00739414) | Novartis Pharmaceuticals | 2008-07-01 |
| LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib (NCT00680901) | Novartis Pharmaceuticals | 2008-06-04 |
| Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor (NCT00633295) | Novartis Pharmaceuticals | 2008-06-01 |
| Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) (NCT01483014) | Novartis Pharmaceuticals | 2008-06-01 |
| Safety and Efficacy of AIN457 in Noninfectious Uveitis (NCT00685399) | Novartis Pharmaceuticals | 2008-06-01 |
| Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%) (NCT00728351) | Novartis Pharmaceuticals | 2008-06-01 |
| 3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs (NCT00718861) | Novartis Pharmaceuticals | 2008-05-01 |
| Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast® (NCT00668200) | Novartis Pharmaceuticals | 2008-05-01 |
| Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension (NCT00699192) | Novartis Pharmaceuticals | 2008-05-01 |
| Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma (NCT00699296) | Novartis Pharmaceuticals | 2008-05-01 |
| Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma. (NCT00532675) | Novartis Pharmaceuticals | 2008-04-22 |
| Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists (NCT00670930) | Novartis Pharmaceuticals | 2008-04-01 |
| Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies (NCT00669097) | Novartis Pharmaceuticals | 2008-04-01 |